We drive innovation,
guided by the belief that caring for one patient

can improve the health of society as a whole.

Shaping a healthier world.

Mission & Vision

Our mission is to enhance the quality of life for people worldwide, and our vision is to become a global leader in the healthcare industry.

GC Biopharma is an R&D-driven company focused on developing essential and challenging medicines. As a leading biopharmaceutical company in South Korea, we have grown alongside the nation’s biotech sector and are now expanding our presence on the global stage.

Core Values

Challenge
& Innovation

For over half a century, we’ve advanced human health by pushing boundaries. We are dedicated to enhancing our R&D efforts to uphold the reputation and trust we’ve built.

Care
& Compassion

Our commitment extends beyond curing illnesses; we aim to restore hope. We develop treatments for patients with rare diseases and actively support vulnerable and underserved communities.

Transparency
& Integrity

We are guided by the principle of doing what’s right, no matter how challenging the path. Our commitment to integrity remains steadfast, even in the face of adversity.

Respect
& Dedication

Respect for life is at the heart of everything we do. We strive to create a positive impact not only for patients and healthcare professionals but also for our shareholders and partners.

Our Affiliates

GC Biopharma USA

GC Biopharma USA, Inc.
North American Hub for Expanding Pharmaceutical Reach

Established in 2018, GC Biopharma USA serves as the gateway for GC Biopharma products in the U.S. market. The company is a key hub for distributing blood products across North America, including Alyglo (known as IV-Globulin SN Injection 10% in Korea), which received FDA approval in 2023.

  • Address500 Frank W Burr Blvd, Teaneck, NJ 07666 USA

  • Contact+01 (833)426-6426

  • Emailinfo@gcbiopharma.us

GC Biopharma USA

GC DO BRASIL CONSULTORIA DE NEGÓCIOS LTDA
Driving Growth in Brazil and Across Latin America

GC DO BRASIL was established in 2018 as part of GC Biopharma's strategy to expand its footprint in Latin America. The company facilitates the distribution of blood products, vaccines, and therapies for rare conditions, supporting regional growth.

  • AddressAv. Roque Petroni Junior, 1.089, Conjuntos 214 e 216, Jardim das Acácias, CEP 04707-000, São Paulo, SP, Brazil

  • Contact+55 11 2597 5963